Startseite Crystal structure of tetraaqua-bis(1,3-benzimidazol-3-ium-1,3-diacetato-κO)copper(II) hemihydrate, C22H27CuN4O12.50
Artikel Open Access

Crystal structure of tetraaqua-bis(1,3-benzimidazol-3-ium-1,3-diacetato-κO)copper(II) hemihydrate, C22H27CuN4O12.50

  • Qian Zhang EMAIL logo , Lei Chen und Qiong-Yan Yu
Veröffentlicht/Copyright: 7. April 2017

Abstract

C22H27CuN4O12.50, triclinic, P1̅ (no. 2), a = 7.3950(11) Å, b = 9.4574(15) Å, c = 9.6619(15) Å, α = 81.139(2)°, β = 75.457(3)°, γ = 77.974(3)°, V = 636.02(17) Å3, Z = 1, Rgt(F) = 0.0371, wRref(F2) = 0.1020, T = 293 K.

CCDC no.:: 1507688

The crystal structure is shown in the figure. Tables 1 and 2 contain details on crystal structure and measurement conditions and a list of the atoms including atomic coordinates and displacement parameters.

Table 1

Data collection and handling.

Crystal:Blue plate
Size:0.50 × 0.45 × 0.11 mm
Wavelength:Mo Kα radiation (0.71073 Å)
μ:9.3 cm−1
Diffractometer, scan mode:Bruker P4, ωscans
2θmax, completeness:51.4°, >98%
N(hkl)measured, N(hkl)unique, Rint:3397, 2366, 0.014
Criterion for Iobs, N(hkl)gt:Iobs > 2 σ(Iobs), 2249
N(param)refined:192
Programs:SHELX [17]
Table 2

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

AtomxyzUiso*/Ueq
Cu1.00000.00001.00000.02919(16)
O10.9198(3)0.09727(19)0.8221(2)0.0420(4)
O20.9058(3)−0.0791(2)0.6978(2)0.0509(5)
O30.4092(3)0.6515(2)0.8733(3)0.0531(5)
O40.5419(3)0.7807(2)0.9800(2)0.0489(5)
O1W0.6940(3)−0.0372(2)1.0958(2)0.0479(5)
H1WA0.61960.03091.06650.074(13)*
H1WB0.6661−0.10481.05170.079(12)*
O2W0.9419(3)0.19533(19)1.0746(2)0.0374(4)
H2WB0.97390.18721.15120.067(12)*
H2WA0.82650.24241.08810.065(11)*
N10.7415(3)0.3091(2)0.6489(2)0.0300(4)
N20.7474(3)0.5077(2)0.7348(2)0.0301(4)
C90.7481(3)0.4193(2)0.5347(2)0.0284(5)
C110.7456(4)0.4190(3)0.3912(3)0.0380(6)
H110.73910.33540.35430.046*
C10.7390(3)0.3680(3)0.7662(3)0.0324(5)
H10.73220.31770.85740.039*
C100.7525(3)0.5455(3)0.5899(3)0.0299(5)
C30.7627(4)0.6772(3)0.5040(3)0.0409(6)
H30.76830.76110.54070.049*
C50.7535(4)0.5503(3)0.3070(3)0.0471(7)
H50.75170.55510.21050.056*
C40.7640(4)0.6758(3)0.3609(3)0.0498(7)
H40.77200.76100.29900.060*
C70.5477(4)0.6866(3)0.9009(3)0.0345(5)
C60.7447(4)0.6058(3)0.8385(3)0.0374(6)
H6A0.82540.67620.79180.045*
H6B0.79780.55000.91660.045*
C80.8706(3)0.0480(3)0.7262(3)0.0322(5)
C120.7468(4)0.1552(3)0.6380(3)0.0397(6)
H12A0.79280.13780.53780.048*
H12B0.61820.13560.66860.048*
O3Wa0.6239(16)0.0560(11)0.3762(10)0.066(3)
H3WAa0.64810.06990.28070.079*
H3WBa0.5687−0.02850.39630.079*
  1. aOccupancy: 0.25.

Source of material

The ligand 1-(carboxymethyl)-1H-benzimidazol-3-ium-3-acetate was prepared according to the reported procedures [1]. Solid sodium carbonate (0.25 mmol) was added to 1-(carboxymethyl)-1H-benzimidazol-3-ium-3-acetate (0.5 mmol) in distilled water (5 mL) while stirring at room temperature. Once the solution became clear, copper(II) nitrate hexahydrate (0.25 mmol) disolved in distilled water (5 mL) was added dropwise. After continuous stirring for 15 min, the resulting blue solution was filtered and placed undisturbed for 2 weeks. During this period blue crystals were obtained.

Experimental details

All the hydrogen atoms except that of water were generated geometrically and refined isotropically using riding models. The Uiso values of the hydrogen atoms were set to 1.2Ueq(C). The hydrogen of water molecules were found directly from different Fourier map.

Discussion

In the recent years, the benzimidazole derivatives and their metal complexes have attracted much attention because of the specific topological frameworks and interesting properties of these compounds [2], [3], [4], [5]. Furthmore, benzimidazole carboxylic acids and their derivatives are widely used due to their biological activites such as antifilarial, antineoplastic, anthelmintic and antiviral activities [6], [7], [8], [9]. Up to now, several complexes have been synthesized using the benzimidazole carboxylic acid [10], [11], [12], [13], [14], [15], [16]. To extend this research, we used 1,3-benzimidazol-3-ium-1,3-diacetato ligand to react with Cu2+ ions and got a new complex.

The asymmetric unit of the title structure consists of one half of a monomer complex (cf. the figure, the asymmetric unit is labeled) and one uncoordinated water molecule with the occupation of 25%. The Cu(II) atom lies on the inversion center and is six-coordinated by four O atoms from four coordinated water molecules and two O atoms from two monodentate coordinating ligands. The Cu(II) atom adopts a slightly distorted octahedral geometry. The axial Cu—O bond distances are in the range of 1.986(2) Å and 2.298(2) Å. The benzimidazolium moiety (C1/N1/C9/C11/C5/C4/C3/C10/N2) is essentially planar, with a mean deviation of 0.0124 Å. The carboxylate groups adopt trans conformations, with the C10—N2—C6—C7 and C9—N1—C12—C8 torsion angles to be 84.26° and 138.48°, respectively. In the crystal structure, the coordinated water molecules are hydrogen-bonded to carboxylate O atoms to generate a two-dimensional network parallel to the ab plane (O2W—H2WB⋯O2′ 2.703(3) Å; O2W—H2WA⋯O3′′, 2.663(3) Å; O1W—H1WA⋯O4, 2.794(3) Å; O1W—H1WB⋯O4′′′, 2.740(3) Å; ′ = 2 − x, −y, 2 − z; ′′ = 1 − x, 1 − y, 2 − z; ′′′ = x, −1 + y, z). The two-dimensional network are further extended into a three-dimensional supramolecular structure along the crystallographic c direction via π–π stacking interactions between benzimidazolium rings from adjacent layers, with a centroid-centroid distance of 3.588 Å.

Acknowledgement

This work was supported by the Foundation of Education Committee of Henan province, China (No. 14 A150035), and the Doctor Foundation of Henan institue of Engineering (No. D2012030).

References

1 Chen, D. B.; Huang, L.: 1-(Carboxymethyl)-1,3-benzimidazol-3- ium-3-acetate. Acta Crystallogr. E62 (2006) o4686–o4688.10.1107/S1600536806038335Suche in Google Scholar

2 Wen, Q. Y.; Chen, J. Q.; Fang, H. C.; Chen, L.; Zhou, Z. Y.; Hu, Z. J.; Cai Y. P.: Construction of ZnII-based rac-helical chains containing semi-rigid dipolar ligand 1,4-bis(benzimidazol-1-ylmethyl) benzene. Z. Anorg. Allg. Chem. 635 (2009) 567–571.10.1002/zaac.200801233Suche in Google Scholar

3 Lu, H. J.; Fan, Y. T.; Gao, J.; Wang, Q.: 1,4–Bis(1–benzimidazolylmethyl)benzene with Cd(II) and Zn(II) cations: Synthesis and crystal structures of a 2-D coordination polymer and a 3-D supramolecular. Synth. React. Inorg. M. 35 (2005) 305–309.10.1081/SIM-200055247Suche in Google Scholar

4 Liu, X. C.; Guo, X. L.; Niu, Y. Y.; Wang, Q. L.; Cui, Q.; Hou, H. W.; Lv, X. R.; Ng, S. K.: Synthesis and structure of a CdI2 coordination polymer with 1,4-bis(benzimidazole-1-yl-methylene)benzene (bbmb). J. Chem. Crystallogr. 39 (2009) 147–150.10.1007/s10870-008-9445-4Suche in Google Scholar

5 Su, C. Y.; Cai, Y. P.; Chen, C. L.; Smith, M. D.; Kaim, W.; zur Loye, H. C.: Ligand-directed molecular architectures: Self-assembly of two-dimensional rectangular metallacycles and three-dimensional trigonal or tetragonal prisms. J. Am. Chem. Soc. 125 (2003) 8595–8613.10.1021/ja034267kSuche in Google Scholar

6 Dubey, R.; Abuzar, S.; Sharma, S.; Chatterjee, R. K.; Katiyar, J. C.: Synthesis and anthelmintic activity of 5(6)-[benzimidazole-2-yl)carboxamido]-and (4-substituted piperazin-l-y) benzimidazoles. J. Med. Chem. 28 (1985) 1748–1750.10.1021/jm00149a036Suche in Google Scholar

7 Garuti, L.; Roberti, M.; Gentilomi, G.: Synthesis and antiviral assays of some 2-substituted benzimidazole-N-carbamates. Farmaco 55 (2000) 35–39.10.1016/S0014-827X(99)00117-2Suche in Google Scholar

8 López-Rodríguez, M. L.; Benhamú, B.; Viso, A.; Morcillo, M. J.; Murcia, M.; Orensanz, L.; Alfaro, M. J.; Martín, M. I.: Synthesis and structure-activity relationships of new benzimidazole-4-carboxamides and carboxylates as potent and selective 5-HT4 Receptor Antagonists. Bioorg. Med. Chem. 7 (1999) 2271–2281.10.1016/S0968-0896(99)00172-8Suche in Google Scholar

9 Poeta, M. D.; Schell, W. A.; Dykstra, C. C.; Jones, S.; Tidwell, R. R.; Czarny, A.; Bajic, M.; Kumar, A.; Boykin, D.; Perfect, J. R.: Structure-in vitro activity relationships of pentamidine analogues and dication-substituted bis-benzimidazoles as new antifungal agents. Antimicro. Agents Chemother. 42 (1998) 2495–2502.10.1128/AAC.42.10.2495Suche in Google Scholar PubMed PubMed Central

10 Fei, Z.; Geldbach, T. J., Zhao, D.; Scopelliti, R.; Dyson, P. J.: Anearly planar water sheet sandwiched between strontium-imidazolium carboxylate coordination polymers. Inorg. Chem. 44 (2005) 5200–5202.10.1021/ic0504238Suche in Google Scholar PubMed

11 Fei, Z.; Zhao, D.; Geldbach, T. J.; Scopelliti, R.; Dyson, P. J.; Antonijevic, S.: A synthetic zwitterionic water channel: characterisation in the solid state by X-ray crystallography and NMR spectroscopy. Angew. Chem. 117 (2005) 5866–5871.10.1002/ange.200500207Suche in Google Scholar

12 Huang, L.; Chen, D. B.: Tetraaquabis(1,3-benzimidazol-3-ium-1,3-diacetato)cobalt(II) hemihydrate. Acta Crystallogr. E62 (2006) m3532–m3534.10.1107/S1600536806049920Suche in Google Scholar

13 Huang, L.; Chen, D. B.: Tetraaquabis[1-(carboxylatomethyl)-1,3-benzimidazol-3-ium-3-acetato-κO]manganese(II) dihydrate. Acta Crystallogr. E62 (2006) m2872–m2874.10.1107/S1600536806040645Suche in Google Scholar

14 Huang, L.; Chen, D. B.: Crystal structure of hexaaquanickel(II) bis[1-(carboxylatomethyl)-1,3-benzimidazol-3-ium-3-acetato] dihydrate. Z. Kristallogr. -NCS 223 (2008) 163–164.Suche in Google Scholar

15 Wang, B. L.; Li, J. P.; Li, G.; Zhu, L.; Bao, G. L.: Synthesis, crystal structures and properties of Zn(II) and Cd(II) Complexes constructed from benzimidazolyl carboxylic acid. Synth. React. Inorg. M. 38 (2008) 750–757.10.1080/15533170802525837Suche in Google Scholar

16 Huang, L.; Zhong, A. G.; Chen, D. B.; Qiu, D.; Liang, H. D.: Synthesis, structure, spectroscopic properties, and theoretical studies of alkaline earth metal complexes of 1,3-bis(carboxymethyl) benzimidazolium. J. Mol. Struct. 984 (2010) 39–50.10.1016/j.molstruc.2010.09.005Suche in Google Scholar

17 Sheldrick, G. M.: A short history of SHELX. Acta Crystallogr. A64 (2008) 112–122.10.1107/S0108767307043930Suche in Google Scholar PubMed

Received: 2016-11-15
Accepted: 2017-3-20
Published Online: 2017-4-7
Published in Print: 2017-5-24

©2017 Qian Zhang et al., published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Artikel in diesem Heft

  1. Cover and Frontmatter
  2. Crystal structure of 2,5-diiodo-4-nitro-1H-imidazole hemihydrate, C6H4I4N6O5
  3. Crystal structure of catena-poly[μ2-2,2′-(1,3-phenylene)diacetato-κ4O,O′:O′′,O′′′)-(μ2-1,6-bis(2-methyl-1H-benzo[d]imidazol-1-yl)hexane-κ2N:N′)cadmium(II)], C32H34CdN4O4
  4. Crystal structure of poly[aqua-(2,2′-bipyridine-κN,N′)-(μ4-5,5′-(hexane-1,6-diyl)-bis(oxy)diisophthalato κ8O1,O2:O3,O4:O5,O6:O7,O8)manganese(II)], C21H21MnN2O7
  5. Crystal structure of poly-[(μ2-((1,3-bis(benzimidazol-1-yl)propane-κ2N:N′)(μ2-4-tert-butyl-phthalato-κ2O:O′)cobalt(II)] monohydrate, C29H30CoN4O5
  6. Crystal structure of 2-amino-4-(3,4,5-trimethoxy-phenyl)-5-(oxo-5,6,7,8-tetrahydro-4H-chromene)-3-carbonitrile – ethanol (1/1), C21H26N2O6
  7. Crystal structure of ethyl 1-benzyl-5-phenyl-1H-pyrazole-3-carboxylate, C19H18N2O2
  8. Crystal structure of 2-(1-benzyl-3-phenyl-1H-pyrazol-5-yl)-5-(4-nitrobenzylthio)-1,3,4-oxadiazole, C25H19N5O3S
  9. Structure and photochromism of 1,2-bis[2-methyl-5-(2-chlorophenyl)-3-thienyl]-3,3,4,4,5,5-hexafluorocyclopent-1-ene, C27H16Cl2F6S2
  10. The crystal structure of the Schiff base (E)-2,6-diisopropyl-N-(pyridin-4-ylmethylene)aniline, C18H22N2
  11. Crystal structure of (E)-2,4-dibromo-6-(((4-methyl-2-nitrophenyl)imino) methyl)phenol, C10H14Br2N2O3
  12. Crystal structure of (bis(2,2′-bipyridine-κ2N,N′))-(3,5-dinitrosalicylato-κ2O,O′)nickel(II), C27H18N6NiO7
  13. Crystal structure of 1-(diethoxy phosphonomethyl) 2-benzoyl-3-chloro-2-cyclohexen-1-ol, C18H24ClO5P
  14. Crystal structure of tetraaqua-bis(1,3-benzimidazol-3-ium-1,3-diacetato-κO)copper(II) hemihydrate, C22H27CuN4O12.50
  15. Crystal structure of 1α,11-dihydroxyeremophil-9-en-8-one, C15H24O3
  16. Crystal structure of 1-ferrocenylsulfonyl-1H-imidazo[4,5-b]pyridine, C16H13FeN3O2S
  17. Crystal structure of bis(μ2-azido-κ2N:N)-dichlorido-bis(μ2-2-(pyridin-2-yl)ethan-1-ol-κ2O,N)dicopper(II), C14H18Cl2Cu2N8O2
  18. Crystal structure of (5,15-cis-bis(2-hydroxy-1-naphthyl)-10-phenyl-20-(4-hydroxyphenyl)-porphyrinato)-(pyridine)-zinc(ii) pyridine solvate, C67H47N7O3Zn
  19. Crystal structure of (μ2-[2,2′-bis(diphenylphosphino)-1,1′-binaphthalene oxide-κ2O,P])-iodido copper(I), C44H32CuIOP2
  20. Crystal structure of 6,8-diphenyl-2-(4-fluorophenyl)-2,3-dihydroquinolin-4(3H)-one, C27H20FNO
  21. Crystal structure of 5,11,17,23-tetra(tert-butyl)-25,26,27,28-tetrahexoxycalix[4]arene, C68H104O4
  22. Crystal structure of N,N′–bis(pyridin-4-ylmethyl)pyrazine-2,3-dicarboxamide dihydrate, C18H20N6O4
  23. Crystal structure of a diaqua-bis(3,5-di(1H-imidazol-1-yl)pyridine-κN)-bis(2-(4-carboxy-phenyl)acetato-κO]manganese(II), C40H36MnN10O10
  24. Crystal structure of 4-(4-hydroxy-3-methoxy-phenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydro-quinoline-3-carboxylic acid methyl ester, C21H25NO5
  25. Crystal structure of (E)-4,4′-(ethene-1,2-diyl)bis(3-nitrobenzoic acid) 1.5 hydrate, C16H13N2O9.5
  26. Crystal structure of (E)-2-(5-(4-fluorophenyl)-3-(furan-2-yl)-4,5-dihydro-1H-pyrazol-1-yl)-5-((4-fluorophenyl)diazenyl)-4-methylthiazole, C23H17F2N5OS
  27. Crystal structure of the co-crystalline adduct 4-((4,4-dimethyl-2,6-dioxocyclohexylidene)methylamino)-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide - acetic acid (1/1), C21H24N4O4S ⋅ C2H4O2
  28. Synthesis and crystal structure of 2-((5-chlorobenzo[c][1,2,5]thiadiazol-4-yl)amino)-4,5-dihydro-1H-imidazol-3-ium tetraphenylborate, C33H29BClN5S
  29. Crystal structure of (4-chlorophenyl)(3-ferrocenyl-5-(trifluoromethyl)-1H-pyrazol-1-yl)methanone, C21H14ClF3FeN2O
  30. Crystal structure of (S)-benzyl 3-(benzylcarba-moyl)-3,4-dihydroisoquinoline-2(1H)-carboxylate, C25H24N2O3
  31. Crystal structure of 5-acetyl-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one, C15H17FN2O4
  32. Crystal structure of 2-(4-fluorophenyl)-1,3-dimethyl-1H-perimidin-3-ium iodide, C19H16FIN2
  33. Crystal structure of methyl 1H-indole-2-carboxylate, C10H9NO2
  34. Crystal structure of 2,3-diphenyl-1-[(dipropylamino)acetyl]-1,3-diazaspiro[4.5]decan-4-one, C28H37N3O2
  35. Crystal structure of 1-(2H-1,3-benzodioxol-5-yl)-3-(1H-imidazol-1-yl)propan-1-one, C13H12N2O3
  36. Crystal structure of 2,9-dibromo-1,10-phenanthroline, C12H6Br2N2
  37. Crystal structure of 3-(adamantan-1-yl)-4-(4-fluorophenyl)-1H-1,2,4-triazole-5(4H)-thione, C18H20FN3S
  38. Crystal structure of trans-bis((E)-7-oxo-4-(phenyldiazenyl)cyclohepta-1,3,5-trien-1-olato)-κ2O,O′)-bis(pyridine-κN)cobalt(II), C36H28CoN6O4
  39. Crystal structure of 2-(4-methyl-3-phenylthiazol-2(3H)-ylidene)malononitrile, C13H9N3S
  40. Crystal structure of (Z)-3-(adamantan-1-yl)-1-(3-chlorophenyl)-S-benzylisothiourea, C24H27ClN2S
  41. Crystal structure of chlorido{[3-(η5-cyclopenta-dienyl)-2,2,3-trimethyl-1-phenylbutylidene] azanido-κN}[η2(N,O)-N,N-dimethylhydroxylaminato]titanium(IV), C20H27ClN2OTi
  42. Crystal Structure of 1,1′-dimethyl-[4,4′-bipyridine]-1,1′-diium tetrachloridozincate(II), C12H14Cl4N2Zn
  43. Crystal structure of 5-nitro-2-(pyrrolidin-1-yl)benzaldehyde, C11H12N2O3
  44. Crystal structure of 2,3-diphenyl-1-(morpholin-4-ylacetyl)-1,3-diazaspiro[4.5]decan-4-one, C26H31N3O3
  45. Crystal structure of 3,3-dimethyl-3,4-dihydro-1H-benzo[c]chromene-1,6(2H)-dione, C15H14O3
  46. Crystal structure of bis(2-(2-hydroxymethyl)pyridine-κ2N,O)-bis(pivalato-κO)nickel(II), C22H32N2NiO6
  47. Crystal structure of (1,10-phenanthroline-κ2N,N′)-bis(1H-pyrazole-3-carboxylato-κ2N,O)manganese(II) trihydrate, C20H20N6O7Mn
  48. The crystal structure of 3-aminopropan-1-aminium iodide, C3H11N2I
  49. Crystal structure of ethyl 1-(4-chlorophenyl)-5-methyl-1H-1,2,3-triazole-4 carboxylate, C12H12ClN3O2
  50. Crystal structure of 4,4′-((1Z,1′Z)-2,2′-(2,5-diethoxy-1,4-phenylene)bis(ethene-2,1-diyl))dipyridine, C24H24N2O2
  51. Crystal structure of (16S)-12,16-epoxy-11,14-dihydroxy-17(15/16)-abeo-3a,18-cyclo-8,11,13-abietatrien-7-one, C20H24O4
  52. Crystal structure of aquadichlorido(2,4,6-tri-2-pyridyl-1,3,5-triazine-κ3N,N′,N′′)nickel(II) monohydrate, C18H16Cl2N6NiO2
  53. Crystal structure of catena-poly[dichlorido-(μ-ethane-1,2-diyl-bis-(pyridyl-4-carboxylate-κN:N′)mercury(II)], C15H14Cl2HgN2O4
  54. Crystal structure of methyl 2-acetamido-5-chlorbenzoate, C10H10ClNO3
  55. Crystal structure of tetrakis(μ2-3,3-dimethylacrylato-κ2O,O′)-bis(2-aminopyrimidine-κN) dicopper(II), C28H38Cu2N6O8
  56. Crystal structure of 3-amino-8-methoxy-1-phenyl-1H-benzo[f]chromene-2-carbonitrile, C21H16N2O2
  57. Crystal structure of 4-(2-ammonioethyl)morpholin-4-ium dichloride monohydrate, C6H18Cl2N2O2
  58. Crystal structure of 1-(3-((5-bromo-2-hydroxybenzylidene)amino)phenyl)ethanone O-benzyl oxime, C22H19BrN2O2
  59. Crystal structure of 2-(4-(dimethylamino)-2-fluorophenyl)-1,3-bis(1H-1,2,4-triazol-1-yl)propan-2-ol monohydrate, C15H20FN7O2
  60. Crystal structure of 4-bromo-2-(1H-pyrazol-3-yl)phenol, C9H7BrN2O
  61. Crystal structure of 1,2,3,4,5-pentamethyl-1,3-cyclopentadiene, C10H16
Heruntergeladen am 22.11.2025 von https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2016-0273/html?lang=de
Button zum nach oben scrollen